Cysteine Protease Cathepsins in Atherosclerosis-Based Vascular Disease and Its Complications
Authors:
- 1 December 2011
- journal article
- review article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 58 (6) , 978-986
Abstract
Atherosclerosis-based vascular disease is an inflammatory disease characterized by extensive remodeling of the extracellular matrix architecture of the arterial wall. Although matrix metalloproteinases and serine proteases participate in these pathological events, the discovery of cysteine protease cathepsins, such as cathepsins K, S, L, and B, and cystatin C, and their tissue distribution has suggested that at least some of them participate in cardiovascular disease. Studies on vascular cells have shown that atherosclerosis-associated inflammatory cytokines augment cysteinyl cathepsin expression and activity. Novel insight into cathepsin functions has been made possible by the generation and in-depth analysis of knockout and transgenic mice. These studies have provided direct evidence implicating cathepsins in atherosclerosis-based vascular disease through the activation, liberation, and modification of angiogenic growth factors, cytokines, and proteases associated with lipid metabolism, cell events (migration, invasion, proliferation, and apoptosis), angiogenesis, and matrix protein remodeling. Furthermore, evaluation of the feasibility of cathepsins as a diagnostic tool has revealed that the serum cathepsins S and L and the endogenous inhibitor cystatin C hold promise as biomarkers of coronary artery disease and aneurysm formation. The goal of this review is to summarize the available information regarding the mechanistic contributions of cathepsins in atherosclerosis-based vascular disease.Keywords
This publication has 95 references indexed in Scilit:
- Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseasesPharmacology & Therapeutics, 2011
- Inhibition of mineralocorticoid receptor is a renoprotective effect of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor pitavastatinJournal Of Hypertension, 2011
- Systemic Administration of Ribbon-type Decoy Oligodeoxynucleotide Against Nuclear Factor κB and Ets Prevents Abdominal Aortic Aneurysm in Rat ModelMolecular Therapy, 2011
- Usefulness of Serum Cathepsin L as an Independent Biomarker in Patients With Coronary Heart DiseaseThe American Journal of Cardiology, 2009
- Cathepsin K Activity-dependent Regulation of Osteoclast Actin Ring Formation and Bone ResorptionJournal of Biological Chemistry, 2009
- Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1American Journal of Physiology-Renal Physiology, 2008
- Major Role of Cathepsin L for Producing the Peptide Hormones ACTH, β-Endorphin, and α-MSH, Illustrated by Protease Gene Knockout and ExpressionJournal of Biological Chemistry, 2008
- Role of Smooth Muscle Cells in the Initiation and Early Progression of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Cysteine protease cathepsin X modulates immune response via activation of β2 integrinsImmunology, 2008
- Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of LysosomesCell, 2001